FTC Issues Final Rule Expanding Hart-Scott-Rodino Act Reporting Obligations for the Transfer of Pharmaceutical Patent Rights
The Federal Trade Commission (“FTC”) has finalized amendments to the premerger notification rules under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) expanding and to some extent clarifying the reporting requirements for the transfer of rights involving pharmaceutical patents. The final rule will become effective 30 days after publication in the Federal Register, which will likely happen within the next day or so.